FDA's new playbook: Lots of media announcements but not much rulemaking
Associated Press
1 / 5
Health and Human Services Secretary Robert F. Kennedy Jr. testifies before a Senate Committee on Finance hearing on Capitol Hill, Wednesday, April 22, 2026, in Washington. (AP Photo/Jose Luis Magana)President Donald Trump shakes hands with U.S. Secretary of Health and Human Services Robert Kennedy Jr. in the Oval Office of the White House, Saturday, April 18, 2026, in Washington. (AP Photo/Julia Demaree Nikhinson)Dr. Marty Makary, Food and Drug Administration (FDA) commissioner, attends an event on health care affordability in the Oval Office at the White House, Thursday, April 23, 2026, in Washington. (AP Photo/Mark Schiefelbein)Dr. Marty Makary, commissioner of the Food and Drug Administration, center, speaks while National Institutes of Health Director Dr. Jay Bhattacharya, left, and Health and Human Services Secretary Robert F. Kennedy Jr., right, listen in the Oval Office of the White House, Saturday, April 18, 2026, in Washington. (AP Photo/Julia Demaree Nikhinson)Health and Human Services Secretary Robert F. Kennedy Jr. attends an event on health care affordability in the Oval Office at the White House, Thursday, April 23, 2026, in Washington. (AP Photo/Mark Schiefelbein)
Health and Human Services Secretary Robert F. Kennedy Jr. testifies before a Senate Committee on Finance hearing on Capitol Hill, Wednesday, April 22, 2026, in Washington. (AP Photo/Jose Luis Magana)